Protagenic Therapeutics Inc (PTIXW) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.03
• 52-Week High: $0.24
• 52-Week Low: $0.00

About Protagenic Therapeutics Inc

Protagenic Therapeutics, Inc. (PTIXW) is a forward-looking biopharmaceutical company headquartered in New York, dedicated to developing innovative therapies for stress-related mood and neuropsychiatric disorders. With a focus on addressing significant unmet medical needs in mental health, Protagenic applies its deep expertise in neurobiology to identify and develop novel treatment solutions that may enhance patient outcomes. The company's robust research initiatives are focused on exploring g...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Protagenic Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PTIXW pay dividends?

Protagenic Therapeutics Inc (PTIXW) does not currently pay a regular dividend.